Rocket


News + Filings
Transactions
Holdings



Rock Springs Capital Management LP

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
10/26/2021Xilio Therapeutics, Inc. ConversionCommon Stock756.5k$0.00$0See footnote10/26/2021
10/26/2021Xilio Therapeutics, Inc. ConversionCommon Stock151.3k$0.00$0See footnote10/26/2021
10/26/2021Xilio Therapeutics, Inc. PurchaseCommon Stock500k$16.00$8MSee footnote10/26/2021
10/26/2021Xilio Therapeutics, Inc. ConversionSeries C Preferred Stock7.2M$0.00$0See footnote10/26/2021
10/26/2021Xilio Therapeutics, Inc. ConversionSeries C Preferred Stock1.4M$0.00$0See footnote10/26/2021
10/12/2021Theseus Pharmaceuticals, Inc.THRXConversionCommon Stock349.3k$0.00$0See Footnote10/12/2021
10/12/2021Theseus Pharmaceuticals, Inc.THRXConversionCommon Stock87.3k$0.00$0See Footnote10/12/2021
10/12/2021Theseus Pharmaceuticals, Inc.THRXPurchaseCommon Stock250k$16.00$4MSee Footnote10/12/2021
10/12/2021Theseus Pharmaceuticals, Inc.THRXConversionSeries B Convertible Preferred Stock349.3k$0.00$0See Footnote10/12/2021
10/12/2021Theseus Pharmaceuticals, Inc.THRXConversionSeries B Convertible Preferred Stock87.3k$0.00$0See Footnote10/12/2021
06/21/2021Verve Therapeutics, Inc. ConversionCommon Stock556.3k$0.00$0See Footnote06/21/2021
06/21/2021Verve Therapeutics, Inc. PurchaseCommon Stock370k$19.00$7MSee Footnote06/21/2021
06/21/2021Verve Therapeutics, Inc. ConversionCommon Stock152.9k$0.00$0See Footnote06/21/2021
06/21/2021Verve Therapeutics, Inc. ConversionSeries B Preferred Stock5.2M$0.00$0See Footnote06/21/2021
06/21/2021Verve Therapeutics, Inc. ConversionSeries B Preferred Stock1.4M$0.00$0See Footnote06/21/2021
11/03/2020Atea Pharmaceuticals, Inc.AVIRConversionSeries D-1 Convertible Preferred Stock521.7k$0.00$0See Footnote11/03/2020
11/03/2020Atea Pharmaceuticals, Inc.AVIRConversionSeries D Convertible Preferred Stock178.1k$0.00$0See Footnote11/03/2020
11/03/2020Atea Pharmaceuticals, Inc.AVIRConversionSeries D-1 Convertible Preferred Stock104.3k$0.00$0See Footnote11/03/2020
11/03/2020Atea Pharmaceuticals, Inc.AVIRConversionCommon Stock282.4k$0.00$0See Footnote11/03/2020
11/03/2020Atea Pharmaceuticals, Inc.AVIRConversionCommon Stock1.4M$0.00$0See Footnote11/03/2020
11/03/2020Atea Pharmaceuticals, Inc.AVIRPurchaseCommon Stock242.7k$24.00$5.8MSee Footnote11/03/2020
11/03/2020Atea Pharmaceuticals, Inc.AVIRPurchaseCommon Stock7.3k$24.00$175kSee Footnote11/03/2020
11/03/2020Atea Pharmaceuticals, Inc.AVIRConversionSeries D Convertible Preferred Stock890.3k$0.00$0See Footnote11/03/2020
07/28/2020Inozyme Pharma, Inc.INZYConversionCommon Stock467.9k$0.00$0See footnote07/28/2020
07/28/2020Inozyme Pharma, Inc.INZYPurchaseCommon Stock576k$16.00$9.2MSee footnote07/28/2020
07/28/2020Inozyme Pharma, Inc.INZYPurchaseCommon Stock24k$16.00$384kSee footnote07/28/2020
07/28/2020Inozyme Pharma, Inc.INZYConversionSeries A-2 Convertible Preferred Stock3.5M$0.00$0See footnote07/28/2020
03/16/2020Enliven Therapeutics, Inc.IMRAPurchaseCommon Stock250k$16.00$4MSee footnote03/16/2020
03/16/2020Enliven Therapeutics, Inc.IMRAConversionSeries B Preferred Stock1.7M$0.00$0See footnote03/16/2020
03/16/2020Enliven Therapeutics, Inc.IMRAConversionCommon Stock273.4k$0.00$0See footnote03/16/2020
04/02/2018Homology Medicines, Inc.FIXXConversionCommon Stock395.8k$0.00$0See footnote04/02/2018
04/02/2018Homology Medicines, Inc.FIXXPurchaseCommon Stock250k$16.00$4MSee footnote04/02/2018
04/02/2018Homology Medicines, Inc.FIXXConversionSeries B Preferred Stock395.8k$0.00$0See footnote04/02/2018
06/22/2015ALPINE IMMUNE SCIENCES, INC.NVLSConversionCommon Stock364.4k$0.00$0By Rock Springs Capital Master Fund LP06/22/2015
06/22/2015ALPINE IMMUNE SCIENCES, INC.NVLSPurchaseCommon Stock200k$14.00$2.8MBy Rock Springs Capital Master Fund LP06/22/2015
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy